Article
Antigen-specific CD8+ T cells mediate a peptide-induced fatal syndrome.
Journal of immunology (Baltimore, Md. : 1950) - 1 Jun 2005
Johnson Aaron J, Mendez-Fernandez Yanice, Moyer Ann M, Sloma Cari R, Pirko Istvan, Block Matthew S, Rodriguez Moses, Pease Larry R
Abstract excerpt
Peptide immunotherapy both activates and suppresses the T cell response against known peptide Ags. Although pretreatment with VP2(121-130) peptide inhibits the development of antiviral CTL specific for the immunodominant D(b):VP2(121-130) epitope expressed during acute Theiler's murine encephalomyelitis virus infection, i.v. injection of this same peptide or MHC tetramers containing the peptide during an ongoing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
